Diabetes is one of the most common health issues that people all over the world are encountering. Speaking of India, the country sees 10% of the total population suffering from diabetes. But, the shocking fact here is that almost one in every two Indians living with diabetes is unaware of their condition!
Diabetes is of two types – Type 1 and Type 2; out of which Type 2 is the more common form seen, with 95% of diabetic patients suffering from it. The Type 2 diabetes can be controlled with the help of proper nutrition, exercise, and weight management. But, there are also required certain kinds of medications to be taken often. One drug that is most commonly used to treat this kind of diabetes is Dulaglutide. Founded in 2015, the drug has been commonly prescribed to diabetic patients. However, there were still, until recently, clinical trials going on over the medication to check for its impacts on the urinary and cardiovascular systems.
Advanced clinical trials conducted for testing Dulaglutide
While the medication has been proven to effectively treat diabetes, the doubt was whether it had any negative effect on any other bodily systems like the cardiovascular and urinary tracts. The good news is that the medication has been found to be absolutely safe and effective against cardiovascular and kidney diseases too! The clinical trials being done on the medication involved 9900 people from 24 countries, for more than five long years! Ultimately, it was researched and determined that the drug reduced cardiovascular events and kidney problems in middle-aged and older people. In fact, cardiovascular risks like heart attacks and strokes were reduced by 12% in patients taking Dulaglutide injections, compared to people taking a placebo. The greatest benefit was seen for heart failure, with a risk reduction of more than 30%. In addition, the drug also reduced the possibility of the development of kidney diseases by 15%. Such incredible results can be obtained when our dedicated countrymen take up clinical research as their career option, and undertake professional courses at reputed institutes like Avigna Clinical Research Institute, to learn and obtain a legitimate diploma in Clinical Research Bangalore.
Why were advanced clinical trials conducted?
What made this study to be taken up was the fact that people with diabetes have seen to observe twice the rate of cardiovascular events like heart attacks and strokes, and up to 40% development of kidney diseases, as compared to non-diabetic people. The trial has clearly shown that Dulaglutide can safely reduce the risks of cardiovascular diseases and kidney diseases, while also improving diabetes control, and modestly lowering weight and blood pressure in middle-aged and old patients with Type-2 diabetes.
How does Dulaglutide work?
Dulaglutide is injected once a week in patients suffering from Type-2 diabetes to lower the glucose level in the body. It works by helping pancreas release the right amount of insulin, when blood sugar levels are high, slowing the emptying of the stomach after a meal, and reducing appetite and weight. The drug has shown good tolerance, modest weight reduction, low-density lipoprotein cholesterol and blood pressure, and a modest increase in heart rate. It is easily available in the Indian market, although being a little expensive. However, as long as it keeps your diabetes, heart rate, blood pressure, weight, cardiovascular system, and urinary system under control, there should be no issue paying a little extra for that one dose of injection; should there?
